Needham lowered the firm’s price target on Sarepta (SRPT) to $125 from $183 and keeps a Buy rating on the shares. The company faced significant pressure following earnings, triggered by the appointment of Vinay Prasad to head CBER, as Dr. Prasad is a known critic of the accelerated approval pathway and Elevidys’ approval in particular, the analyst tells investors in a research note. Sarepta has also lowered FY25 sales guidance, Needham notes, adding however that it still views the stock as “undervalued”.

Protect Your Portfolio Against Market Uncertainty

Discover companies with rock-solid fundamentals in  TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty,  delivered straight to your inbox.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on SRPT:

Disclaimer & DisclosureReport an Issue

Sarepta price target lowered to $58 from $87 at RBC Capital Morning Movers: Disney jumps after first quarter earnings, Abu Dhabi resort plan Sarepta price target lowered to $123 from $184 at Oppenheimer Sarepta price target lowered to $60 from $193 at Baird Sarepta price target lowered to $98 from $112 at Guggenheim

View Comments